Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunological mechanisms of inflammatory diseases caused by gut microbiota dysbiosis: A review
Min’an Zhao, Jiayi Chu, Shiyao Feng, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114985-114985
Open Access | Times Cited: 115

Showing 1-25 of 115 citing articles:

Elucidating the role of diet in maintaining gut health to reduce the risk of obesity, cardiovascular and other age-related inflammatory diseases: recent challenges and future recommendations
Tariq Aziz, Nageen Hussain, Zunaira Hameed, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 82
Diet-Induced Gut Dysbiosis and Leaky Gut Syndrome
Yu-Rim Chae, Yu Ra Lee, Young‐Soo Kim, et al.
Journal of Microbiology and Biotechnology (2024) Vol. 34, Iss. 4, pp. 747-756
Open Access | Times Cited: 21
A Comprehensive Review of the Triangular Relationship among Diet–Gut Microbiota–Inflammation
Nidesha Randeni, Matteo Bordiga, Baojun Xu
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9366-9366
Open Access | Times Cited: 16
Probiotics and Food Bioactives: Unraveling Their Impact on Gut Microbiome, Inflammation, and Metabolic Health
Alice Njolke Mafe, Great Iruoghene Edo, Patrick Othuke Akpoghelie, et al.
Probiotics and Antimicrobial Proteins (2025)
Closed Access | Times Cited: 5
Taming neuroinflammation in Alzheimer's disease: The protective role of phytochemicals through the gut−brain axis
Yoonsu Kim, Jinkyu Lim, Jisun Oh
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117277-117277
Closed Access | Times Cited: 13
Identification of an epilepsy-linked gut microbiota signature in a pediatric rat model of acquired epilepsy
Antonella Riva, Eray Şahin, Greta Volpedo, et al.
Neurobiology of Disease (2024) Vol. 194, pp. 106469-106469
Open Access | Times Cited: 10
Gut-derived immune cells and the gut-lung axis in ARDS
Mairi Ziaka, Aristomenis K. Exadaktylos
Critical Care (2024) Vol. 28, Iss. 1
Open Access | Times Cited: 10
Gut microbiota and type 2 diabetes mellitus: a focus on the gut-brain axis
Yi Pan, Tong Bu, Xia Deng, et al.
Endocrine (2024) Vol. 84, Iss. 1, pp. 1-15
Closed Access | Times Cited: 9
Diverse Colonisation and Disease Associations of the Human Commensal Malassezia: Our Body's Secret Tenant
Jayaprakash Sasikumar, Rumaisa Ali Ebrahim, Shankar Das
Mycoses (2025) Vol. 68, Iss. 1
Closed Access | Times Cited: 1
Hyperbaric Oxygen Therapy in the Treatment of Crohn’s Disease
Jure Krstulović, Goran Augustin, Ivan Romić, et al.
Healthcare (2025) Vol. 13, Iss. 2, pp. 128-128
Open Access | Times Cited: 1
Nano-targeted delivery system: a promising strategy of anthocyanin encapsulation for treating intestinal inflammation
Hao Zhong, Xin Luo, Abdullah, et al.
Critical Reviews in Food Science and Nutrition (2025), pp. 1-22
Closed Access | Times Cited: 1
Modulation of the Neuro–Cancer Connection by Metabolites of Gut Microbiota
Alice Njolke Mafe, Dietrich Büsselberg
Biomolecules (2025) Vol. 15, Iss. 2, pp. 270-270
Open Access | Times Cited: 1
Omega-3 fatty acids and the gut microbiome: a new frontier in cardiovascular disease prevention
Vikram Kumar, Alka Rohilla, Jayesh J. Ahire
Deleted Journal (2025) Vol. 2, Iss. 1
Open Access | Times Cited: 1
The Role of Gut Microbiota-Derived Lithocholic Acid, Deoxycholic Acid and Their Derivatives on the Function and Differentiation of Immune Cells
Yoshimitsu Kiriyama, Hiromi Nochi
Microorganisms (2023) Vol. 11, Iss. 11, pp. 2730-2730
Open Access | Times Cited: 17
Imbalance of gut microbiota is involved in the development of chronic obstructive pulmonary disease: A review
Wei Song, Yuanyi Yue, Qiang Zhang
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115150-115150
Open Access | Times Cited: 16
Endoplasmic reticulum stress: A possible connection between intestinal inflammation and neurodegenerative disorders
Giorgio Vivacqua, Romina Mancinelli, Stefano Leone, et al.
Neurogastroenterology & Motility (2024) Vol. 36, Iss. 5
Open Access | Times Cited: 7
Oral and Gut Microbiota Dysbiosis Due to Periodontitis: Systemic Implications and Links to Gastrointestinal Cancer: A Narrative Review
Yaman Sulaiman, Ingrida Marija Pacauskienė, Renata Šadzevičienė, et al.
Medicina (2024) Vol. 60, Iss. 9, pp. 1416-1416
Open Access | Times Cited: 7
Chitosan and its derivatives: A novel approach to gut microbiota modulation and immune system enhancement
Great Iruoghene Edo, Alice Njolke Mafe, Ali B. M. Ali, et al.
International Journal of Biological Macromolecules (2024) Vol. 289, pp. 138633-138633
Closed Access | Times Cited: 7
Revealing the gut microbiome mystery: A meta-analysis revealing differences between individuals with autism spectrum disorder and neurotypical children
Chang-Jiang Yang, Hongli Xiao, Han Zhu, et al.
BioScience Trends (2024) Vol. 18, Iss. 3, pp. 233-249
Open Access | Times Cited: 6
The Possible Role of Probiotic Supplementation in Inflammation: A Narrative Review
Alessandro Colletti, Marzia Pellizzato, Arrigo F.G. Cicero
Microorganisms (2023) Vol. 11, Iss. 9, pp. 2160-2160
Open Access | Times Cited: 15
Can the Evidence-Based Use of Probiotics (Notably Saccharomyces boulardii CNCM I-745 and Lactobacillus rhamnosus GG) Mitigate the Clinical Effects of Antibiotic-Associated Dysbiosis?
Dan Linetzky Waitzberg, Francisco Guarner, Iva Hojsak, et al.
Advances in Therapy (2024) Vol. 41, Iss. 3, pp. 901-914
Open Access | Times Cited: 5
Gut Microbes in Polycystic Ovary Syndrome and Associated Comorbidities; Type 2 Diabetes, Non-Alcoholic Fatty Liver Disease (NAFLD), Cardiovascular Disease (CVD), and the Potential of Microbial Therapeutics
Vineet Singh, Kanika Mahra, Da-Ryung Jung, et al.
Probiotics and Antimicrobial Proteins (2024) Vol. 16, Iss. 5, pp. 1744-1761
Closed Access | Times Cited: 5
Gut Microbiota-Derived Tryptophan Metabolites Alleviate Allergic Asthma Inflammation in Ovalbumin-Induced Mice
Hongchao Wang, Yuan He, D. C. DANG, et al.
Foods (2024) Vol. 13, Iss. 9, pp. 1336-1336
Open Access | Times Cited: 5
Anti-Hepatic Steatosis Effects of Echinocystic Acid Through Regulation of the Fgfr4/Cyp7a1 Signaling Pathway and Modulating the Gut Microbiota
Lianggui Xiao, Liangshan Qin, Shan Deng, et al.
(2025)
Closed Access
Altered gut microbial profiles in drug-treated rats with alcoholic heart disease
Siang Wei, Yan Feng, Ai Meng, et al.
Journal of Medical Microbiology (2025) Vol. 74, Iss. 1
Closed Access
Page 1 - Next Page

Scroll to top